Current areas of laboratory-based research include basic diabetes research, pancreatic islets, islet transplantation, pathophysiology of diabetes, molecular pathways, insulin-producing cells and stem cell therapies.
YOU ARE EXPLORING
Members of the Division of Pediatric Endocrinology and Diabetology actively participate in numerous clinical and basic research studies, and division members successfully compete for both governmental and non-governmental research funding. The division participates in several national diabetes research consortiums, including Type 1 Diabetes TrialNet, DirecNet, the Type 1 Diabetes Exchange, and the Immune Tolerance Network.
Current clinical research interests include treatment of central precocious puberty, long-term outcomes of central precocious puberty, osteogenesis imperfecta, bone disease in children with cystic fibrosis, hypophosphatasia, congenital hypothyroidism, insulin pump usage in children with type 1 diabetes, endothelial progenitor cells in type 1 diabetes, continuous glucose monitoring in type 1 diabetes, immunomodulatory therapies to prevent or modify type 1 diabetes, quality of life in type 1 diabetes, long-term outcomes of growth hormone treatment, new agents for treatment of growth hormone deficiency, treatment of growth hormone deficiency, treatment of type 2 diabetes, and the relationship of sleep apnea to insulin resistance and obesity.